Bamaprasd Dutta

Dr. Bamaprasd Dutta

Department of Pharmaceutical Sciences, Kumaun University, Nainital, India
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 March 2019 in Oncogene
Verified
Journal Article
Closed access
PDF file
JPJung Eun Park
Jung Eun Park
Bamaprasd DuttaBamaprasd Dutta
Bamaprasd Dutta
STShun Wilford Tse
Shun Wilford Tse
NGNikhil Gupta
Nikhil Gupta
CTChee Fan Tan
Chee Fan Tan
SSSiu Kwan Sze
Siu Kwan Sze

27 August 2015 in eLife
Verified
Journal Article
Open access
ACAlexandre Chojnowski
Alexandre Chojnowski
POPeh Fern Ong
Peh Fern Ong
EWEsther Sm Wong
Esther Sm Wong
JLJohn Sy Lim
John Sy Lim
RMRafidah A Mutalif
Rafidah A Mutalif
ODOliver Dreesen
Oliver Dreesen
Hutchinson-Gilford progeria (HGPS) is a premature ageing syndrome caused by a mutation in LMNA, resulting in a truncated form of lamin A called progerin. Progerin triggers loss of the heterochromatic marker H3K27me3, and premature senescence, which is prevented by telomerase. However, the mechanism how progerin causes disease remains unclear. Here, we describe an inducible cellular system to model HGPS and find that LAP2α (lamina-associated polypeptide-α) interacts with lamin A, while its interaction with progerin is significantly reduced. Super-resolution microscopy revealed that over 50% of telomeres localize to the lamina and that LAP2α association with telomeres is impaired in HGPS. This impaired interaction is central to HGPS since increasing LAP2α levels rescues progerin-induced proliferation defects and loss of H3K27me3, whereas lowering LAP2 levels exacerbates progerin-induced defects. These findings provide novel insights into the pathophysiology underlying HGPS, and how the nuclear lamina regulates proliferation and chromatin organization.

1 February 2013 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
YRYan Ren
Yan Ren
PHPiliang Hao
Piliang Hao
Bamaprasd DuttaBamaprasd Dutta
Bamaprasd Dutta
ECEsther Sok Hwee Cheow
Esther Sok Hwee Cheow
KSKae Hwan Sim
Kae Hwan Sim
SSSiu Kwan Sze
Siu Kwan Sze
Tumor hypoxia induces cancer cell angiogenesis, invasiveness, treatment resistance, and contributes to poor clinical outcome. However, the molecular mechanism by which tumor hypoxia exerts a coordinated effect on different molecular pathways to enhance tumor growth and survival and lead to poor clinical outcome is not fully understood. In this study, we attempt to elucidate the global protein expression and functional changes in A431 epithelial carcinoma cells induced by hypoxia and reoxygenation using iTRAQ quantitative proteomics and biochemical functional assays. Quantitative proteomics results showed that 4316 proteins were quantified with FDR1.2 fold, and DNA repair, glycolysis, integrin, glycoprotein turnover, and STAT1 pathways were perturbed by hypoxia and reoxygenation-induced oxidative stress. For the first time, hypoxia was shown to up-regulate the nonhomologous end-joining pathway, which plays a central role in DNA repair of irradiated cells, thereby potentially contributing to the radioresistance of hypoxic A431 cells. The up-regulation of Ku70/Ku80 dimer, a key molecular complex in the nonhomologous end-joining pathway, was confirmed by Western blot and liquid chromatography/tandem mass spectrometry-MRM methods. Functional studies confirmed that up-regulation of glycolysis, integrin, glycoprotein synthesis, and down-regulation of STAT1 pathways during hypoxia enhanced metastastic activity of A431 cells. Migration of A431 cells was dramatically repressed by glycolysis inhibitor (2-Deoxy-d-glucose), glycoprotein synthesis inhibitor (1-Deoxynojirimycin Hydrochloride), and STAT1α overexpression that enhanced the integrin-mediated cell adhesion. These results revealed that hypoxia induced several biological processes involved in tumor migration and radioresistance and provided potential new targets for tumor therapy.

1 September 2014 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
Bamaprasd DuttaBamaprasd Dutta
Bamaprasd Dutta
YRYan Ren
Yan Ren
PHPiliang Hao
Piliang Hao
KSKae Hwan Sim
Kae Hwan Sim
ECEsther Cheow
Esther Cheow
SSSiu Kwan Sze
Siu Kwan Sze
The chromatin-associated proteome (chromatome) regulates cellular gene expression by restricting access of transcriptional machinery to template DNA, and dynamic re-modeling of chromatin structure is required to regulate critical cell functions including growth and replication, DNA repair and recombination, and oncogenic transformation in progression to cancer. Central to the control of these processes is efficient regulation of the host cell cycle, which is maintained by rapid changes in chromatin conformation during normal cycle progression. A global overview of chromatin protein organization is therefore essential to fully understand cell cycle regulation, but the influence of the chromatome and chromatin binding topology on host cell cycle progression remains poorly defined. Here we used partial MNase digestion together with iTRAQ-based high-throughput quantitative proteomics to quantify chromatin-associated proteins during interphase progression. We identified a total of 481 proteins with high confidence that were involved in chromatin-dependent events including transcriptional regulation, chromatin re-organization, and DNA replication and repair, whereas the quantitative data revealed the temporal interactions of these proteins with chromatin during interphase progression. When combined with biochemical and functional assays, these data revealed a strikingly dynamic association of protein HP1BP3 with the chromatin complex during different stages of interphase, and uncovered a novel regulatory role for this molecule in transcriptional regulation. We report that HP1BP3 protein maintains heterochromatin integrity during G1–S progression and regulates the duration of G1 phase to critically influence cell proliferative capacity.

1 December 2014 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
PDF file
Bamaprasd DuttaBamaprasd Dutta
Bamaprasd Dutta
RYRen Yan
Ren Yan
SLSaikiang Lim
Saikiang Lim
JTJames Tam
James Tam
SSSiu Kwan Sze
Siu Kwan Sze
In contrast to the intensely studied genetic and epigenetic changes that induce host cell transformation to initiate tumor development, those that promote the malignant progression of cancer remain poorly defined. As emerging evidence suggests that the hypoxic tumor microenvironment could re-model the chromatin-associated proteome (chromatome) to induce epigenetic changes and alter gene expression in cancer cells, we hypothesized that hypoxia-driven evolution of the chromatome promotes malignant changes and the development of therapy resistance in tumor cells. To test this hypothesis, we isolated chromatins from tumor cells treated with varying conditions of normoxia, hypoxia, and re-oxygenation and then partially digested them with DNase I and analyzed them for changes in euchromatin- and heterochromatin-associated proteins using an iTRAQ-based quantitative proteomic approach. We identified a total of 1446 proteins with a high level of confidence, including 819 proteins that were observed to change their chromatin association topology under hypoxic conditions. These hypoxia-sensitive proteins included key mediators of chromatin organization, transcriptional regulation, and DNA repair. Furthermore, our proteomic and functional experiments revealed a novel role for the chromatin organizer protein HP1BP3 in mediating chromatin condensation during hypoxia, leading to increased tumor cell viability, radio-resistance, chemo-resistance, and self-renewal. Taken together, our findings indicate that HP1BP3 is a key mediator of tumor progression and cancer cell acquisition of therapy-resistant traits, and thus might represent a novel therapeutic target in a range of human malignancies.

2 November 2017 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
TCTrang T. T. Chu
Trang T. T. Chu
ASAmeya Sinha
Ameya Sinha
Benoit MalleretBenoit Malleret
Benoit Malleret
RSRossarin Suwanarusk
Rossarin Suwanarusk
JPJung E. Park
Jung E. Park
RCRajesh Chandramohanadas
Rajesh Chandramohanadas
Summary: Erythropoiesis is marked by progressive changes in morphological, biochemical and mechanical properties of erythroid precursors to generate red blood cells (RBC). The earliest enucleated forms derived in this process, known as reticulocytes, are multi‐lobular and spherical. As reticulocytes mature, they undergo a series of dynamic cytoskeletal re‐arrangements and the expulsion of residual organelles, resulting in highly deformable biconcave RBCs (normocytes). To understand the significant, yet neglected proteome‐wide changes associated with reticulocyte maturation, we undertook a quantitative proteomics approach. Immature reticulocytes (marked by the presence of surface transferrin receptor, CD71) and mature RBCs (devoid of CD71) were isolated from human cord blood using a magnetic separation procedure. After sub‐fractionation into triton‐extracted membrane proteins and luminal samples (isobaric tags for relative and absolute quantitation), quantitative mass spectrometry was conducted to identify more than 1800 proteins with good confidence and coverage. While most structural proteins (such as Spectrins, Ankyrin and Band 3) as well as surface glycoproteins were conserved, proteins associated with microtubule structures, such as Talin‐1/2 and ß‐Tubulin, were detected only in immature reticulocytes. Atomic force microscopy (AFM)‐based imaging revealed an extended network of spectrin filaments in reticulocytes (with an average length of 48 nm), which shortened during reticulocyte maturation (average spectrin length of 41 nm in normocytes). The extended nature of cytoskeletal network may partly account for increased deformability and shape changes, as reticulocytes transform to normocytes.